Francisco Fidencio Cons Molina

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial

Atul Deodhar, Désirée van der Heijde, Lianne S. Gensler et al. · The Lancet · 2019 · 214 citations

Medicine, Clinical Sciences, Pharmacotherapy +10

Final Report on a Placebo-Controlled, Double-Blind, Randomized, Multicentre Trial of Cyclosporin Treatment in Active Chronic Crohn's Disease

Jørn Brynskov, L Freund, Sten Nørby Rasmussen et al. · Scandinavian Journal of Gastroenterology · 1991 · 89 citations

Medicine, Pharmacology, Pharmacotherapy +10

Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial

Won Park, Ljubinka Božić-Majstorović, Dragana Milaković et al. · mAbs · 2018 · 52 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +17

Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial

Seung Cheol Shim, Ljubinka Božić-Majstorović, Alfredo Berrocal Kasay et al. · Lara D. Veeken · 2019 · 47 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +16

Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis

Won Park, Chang‐Hee Suh, Seung Cheol Shim et al. · BioDrugs · 2017 · 43 citations · Full text

Medicine, Pharmacotherapy, Immunotherapy +11